NTLA logo

Intellia Therapeutics (NTLA)

Profile

Full Name

Intellia Therapeutics, Inc.

Ticker Symbol

NTLA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 6, 2016

Indexes

Not included

Website

http://www.intelliatx.com

Employees

403

Key Details

Price

$8.12(-1.93%)

Market cap

$841.10M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$57.88M(+59.55% YoY)

Annual EPS

-$5.25(+3.14% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.12
    NTLA price is $8.12

    30-Day Relative Volume

    1.40
    NTLA 30-day relative volume is 1.40

    Price Performance

    Price Most recent change

    -1.93%
    NTLA price was down -1.93% on May 9, 2025

    Price YTD change

    -30.36%
    NTLA price is down -30.36% since January 1st

    Price 1-year change

    -67.34%
    NTLA price is down -67.34% year-on-year

    Price 3-year change

    -80.41%
    NTLA price is down -80.41% over the past 3 years

    Price Range

    Price All-time high

    $202.73
    NTLA price is currently -95.99% below its historical high of $202.73

    Price 3-year low

    $5.90
    NTLA price is currently +37.63% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $841.10M
    NTLA market capitalization is $841.10 million

    Market cap 3-year change

    -73.25%
    NTLA market capitalization is down -73.25% over the past 3 years

    Market cap All-time high

    $12.99B
    NTLA market capitalization is currently -93.53% below its historical high of $12.99 billion

    Market cap sector rank

    74.23%
    NTLA market capitalization is higher than 74.23% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +7.37%
    NTLA shares outstanding is up +7.37% year-on-year

    Shares Outstanding 3-Year Change

    +36.56%
    NTLA shares outstanding is up +36.56% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.50
    NTLA beta is 1.50

    200-day SMA

    $14.51
    NTLA price is currently -44.03% below its 200-day simple moving average

    50-day SMA

    $8.29
    NTLA price is currently -2.03% below its 50-day simple moving average

    RSI

    50.39
    NTLA 14-day relative strength index is 50.39

    Volume

    1.40
    NTLA 30-day relative volume is 1.40

    ATR

    $0.66
    NTLA average true range is $0.66

    10-day Historical Volatility

    118.51%
    NTLA 10-day historical volatility is 118.51%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $57.88M
    NTLA annual revenue is $57.88 million

    Revenue Analysts estimate

    $50.03M
    NTLA annual revenue is currently +15.69% higher than the consensus analysts' forecast

    Revenue 1-year change

    +59.55%
    NTLA annual revenue is up +59.55% year-on-year

    Revenue Sector rank

    49.38%
    NTLA annual revenue is higher than 49.38% of companies in Healthcare sector

    EPS

    EPS

    -$5.25
    NTLA annual earnings per share is -$5.25

    EPS Analysts estimate

    -$4.36
    NTLA annual earnings per share is currently +20.29% higher than the consensus analysts' forecast

    EPS 1-year change

    +3.14%
    NTLA annual earnings per share is up +3.14% year-on-year

    EPS Sector rank

    18.44%
    NTLA annual earnings per share is higher than 18.44% of companies in Healthcare sector

    Profit

    Gross profit

    -
    NTLA annual gross profit value is unknown

    Gross margin

    -
    NTLA annual gross profit margin value is unknown

    Operating profit

    -$534.26M
    NTLA annual operating income is -$534.26 million

    Operating margin

    -923.10%
    NTLA annual operating profit margin is -923.10%

    Net income

    -$519.02M
    NTLA annual net profit is -$519.02 million

    Net margin

    -896.77%
    NTLA annual net profit margin is -896.77%

    Expenses

    Total expenses

    $592.14M
    NTLA annual total expenses is $592.14 million

    Operating expenses

    $592.14M
    NTLA annual total operating expenses is $592.14 million

    Cost of goods sold

    -
    NTLA annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $125.83M
    NTLA annual SGA is $125.83 million

    Depreciation and amortization

    $10.29M
    NTLA annual depreciation & amortization is $10.29 million

    Interest expense

    -
    NTLA annual interest expense value is unknown

    Income tax

    -
    NTLA annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$534.26M
    NTLA annual earnings before interest & taxes is -$534.26 million

    EBITDA

    -$523.98M
    NTLA annual EBITDA is -$523.98 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.19B
    NTLA annual total assets is $1.19 billion

    Non current assets

    $551.15M
    NTLA annual long term assets is $551.15 million

    Current assets

    $639.86M
    NTLA annual total current assets is $639.86 million

    Cash and cash equivalents

    $189.18M
    NTLA annual cash & cash equivalents is $189.18 million

    Accounts receivable

    $8.52M
    NTLA annual accounts receivable is $8.52 million

    Inventory

    -
    NTLA annual inventory value is unknown

    Liabilities

    Total liabilities

    $319.06M
    NTLA annual total liabilities is $319.06 million

    Long term liabilities

    $208.21M
    NTLA annual total long term liabilities is $208.21 million

    Current liabilities

    $110.85M
    NTLA annual total current liabilities is $110.85 million

    Accounts payable

    $14.59M
    NTLA annual accounts payable is $14.59 million

    Debt

    Total debt

    $210.20M
    NTLA annual total debt is $210.20 million

    Total debt 1-year change

    +82.23%
    NTLA annual total debt is up +82.23% year-on-year

    Long term debt

    $189.95M
    NTLA annual long term debt is $189.95 million

    Short term debt

    $20.25M
    NTLA annual short term debt is $20.25 million

    Equity & Capital

    Shareholders equity

    $871.96M
    NTLA annual stockholders equity is $871.96 million

    Book value

    $871.96M
    NTLA annual book value is $871.96 million

    Retained earnings

    -$2.18B
    NTLA annual retained earnings is -$2.18 billion

    Working capital

    $529.01M
    NTLA annual working capital is $529.01 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$348.88M
    NTLA annual cash flow from operations is -$348.88 million

    Cash from operations 1-year change

    +11.47%
    NTLA annual cash flow from operations is up +11.47% year-on-year

    Cash from investing

    $125.57M
    NTLA annual cash flow from investing activities is $125.57 million

    Cash from investing 1-year change

    +500.57%
    NTLA annual cash flow from investing activities is up +500.57% year-on-year

    Cash from financing

    $185.75M
    NTLA annual cash flow from financing activities is $185.75 million

    Cash from financing 1-year change

    +42.53%
    NTLA annual cash flow from financing activities is up +42.53% year-on-year

    CAPEX

    CAPEX

    $5.78M
    NTLA annual capital expenditures is $5.78 million

    CAPEX 1-year change

    -58.68%
    NTLA annual capital expenditures is down -58.68% year-on-year

    Free Cash Flow

    Free cash flow

    -$354.66M
    NTLA annual free cash flow is -$354.66 million

    Free cash flow 1-year change

    +13.09%
    NTLA annual free cash flow is up +13.09% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    NTLA annual gross profit margin value is unknown

    Operating margin

    -923.10%
    NTLA annual operating profit margin is -923.10%

    Net margin

    -896.77%
    NTLA annual net profit margin is -896.77%

    ROA & ROE

    ROA

    -41.66%
    NTLA annual return on assets is -41.66%

    ROE

    -54.00%
    NTLA annual return on equity is -54.00%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NTLA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NTLA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.08
    NTLA price to book ratio is 1.08

    PB ratio Sector rank

    45.13%
    NTLA price to book ratio is higher than 45.13% of companies in Healthcare sector

    PS Ratio

    PS ratio

    18.46
    NTLA price to sales ratio is 18.46

    PS ratio Sector rank

    85.41%
    NTLA price to sales ratio is higher than 85.41% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -
    NTLA enterprise value value is unknown

    Enterprise value Sector rank

    -
    NTLA enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    NTLA EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    NTLA EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.77
    NTLA annual current ratio is 5.77

    Quick ratio

    -
    NTLA annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    NTLA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    NTLA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    NTLA piotroski f-score value is unknown

    Altman Z-Score

    -1.88
    NTLA altman z-score is -1.88

    Analyst ratings

    Recent major analysts updates

    May 9, 25 Citigroup
    Neutral
    May 9, 25 Chardan Capital
    Buy
    Apr 21, 25 Wolfe Research
    Outperform
    Mar 5, 25 HC Wainwright & Co.
    Buy
    Mar 4, 25 Truist Securities
    Buy
    Feb 28, 25 Wells Fargo
    Overweight
    Feb 28, 25 JP Morgan
    Neutral
    Feb 28, 25 Citigroup
    Neutral
    Feb 28, 25 Chardan Capital
    Buy
    Feb 28, 25 Barclays
    Overweight

    Institutional Ownership

    Screeners with NTLA included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Intellia Therapeutics?
    • Does Intellia Therapeutics pay dividends?
    • What sector is Intellia Therapeutics in?
    • What industry is Intellia Therapeutics in?
    • What country is Intellia Therapeutics based in?
    • When did Intellia Therapeutics go public?
    • Is Intellia Therapeutics in the S&P 500?
    • Is Intellia Therapeutics in the NASDAQ 100?
    • Is Intellia Therapeutics in the Dow Jones?
    • When was Intellia Therapeutics's last earnings report?
    • When does Intellia Therapeutics report earnings?
    • Should I buy Intellia Therapeutics stock now?

    What is the ticker symbol for Intellia Therapeutics?

    The ticker symbol for Intellia Therapeutics is NASDAQ:NTLA

    Does Intellia Therapeutics pay dividends?

    No, Intellia Therapeutics does not pay dividends

    What sector is Intellia Therapeutics in?

    Intellia Therapeutics is in the Healthcare sector

    What industry is Intellia Therapeutics in?

    Intellia Therapeutics is in the Biotechnology industry

    What country is Intellia Therapeutics based in?

    Intellia Therapeutics is headquartered in United States

    When did Intellia Therapeutics go public?

    Intellia Therapeutics's initial public offering (IPO) was on May 6, 2016

    Is Intellia Therapeutics in the S&P 500?

    No, Intellia Therapeutics is not included in the S&P 500 index

    Is Intellia Therapeutics in the NASDAQ 100?

    No, Intellia Therapeutics is not included in the NASDAQ 100 index

    Is Intellia Therapeutics in the Dow Jones?

    No, Intellia Therapeutics is not included in the Dow Jones index

    When was Intellia Therapeutics's last earnings report?

    Intellia Therapeutics's most recent earnings report was on May 8, 2025

    When does Intellia Therapeutics report earnings?

    The next expected earnings date for Intellia Therapeutics is Aug 8, 2025

    Should I buy Intellia Therapeutics stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page